| scholarly article | Q13442814 |
| P356 | DOI | 10.5551/JAT.12856 |
| P698 | PubMed publication ID | 23037954 |
| P50 | author | Cheuk-Kwan Sun | Q41528783 |
| P2093 | author name string | Chiung-Jen Wu | |
| Hon-Kan Yip | |||
| Pei-Hsun Sung | |||
| Sheung-Fat Ko | |||
| Sarah Chua | |||
| Li-Teh Chang | |||
| Sheng-Ying Chung | |||
| Tzu-Hsien Tsai | |||
| Yung-Lung Chen | |||
| Kuo-Ho Yeh | |||
| Hsuen-Wen Chang | |||
| P433 | issue | 12 | |
| P921 | main subject | myocardial infarction | Q12152 |
| acute myocardial infarction | Q18558122 | ||
| P304 | page(s) | 1073-1082 | |
| P577 | publication date | 2012-10-03 | |
| P1433 | published in | Journal of Atherosclerosis and Thrombosis | Q26842628 |
| P1476 | title | Value and level of galectin-3 in acute myocardial infarction patients undergoing primary percutaneous coronary intervention. | |
| P478 | volume | 19 |
| Q34102031 | Comparison the prognostic value of galectin-3 and serum markers of cardiac extracellular matrix turnover in patients with chronic systolic heart failure |
| Q64996975 | Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction. |
| Q90152813 | Galectin-3 Is a Potential Mediator for Atherosclerosis |
| Q47329197 | Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). |
| Q48035204 | Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention. |
| Q39191329 | Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice |
| Q40792117 | Labeling galectin-3 for the assessment of myocardial infarction in rats |
| Q34524341 | Levels and values of lipoprotein-associated phospholipase A2, galectin-3, RhoA/ROCK, and endothelial progenitor cells in critical limb ischemia: pharmaco-therapeutic role of cilostazol and clopidogrel combination therapy. |
| Q38426618 | Long-term sequelae from acute kidney injury: potential mechanisms for the observed poor renal outcomes |
| Q39017333 | Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling |
| Q33663388 | Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling |
| Q38841682 | Novel biomarkers predicting cardiac function after acute myocardial infarction |
| Q26738521 | Prognostic biomarkers in acute coronary syndrome |
| Q38471023 | Prognostic value of galectin-3 in patients with heart failure |
| Q38177341 | Risk assessment of post-infarction heart failure. Systematic review on the role of emerging biomarkers |
| Q47423482 | The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation |
| Q55035022 | The Therapeutic Potential of Blocking Galectin-3 Expression in Acute Myocardial Infarction and Mitigating Inflammation of Infarct Region: A Clinical Outcome-Based Translational Study. |
| Q38154222 | The emerging role of Galectin-3 and ST2 in heart failure: practical considerations and pitfalls using novel biomarkers |
| Q38727409 | Using the galectin-3 test to predict mortality in heart failure patients: a systematic review and meta-analysis. |
| Q41151739 | Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study |
Search more.